The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1295
ISSUE1295
September 22, 2008
Ciclesonide (Alvesco) - A New Inhaled Corticosteroid for Asthma
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Ciclesonide (Alvesco) - A New Inhaled Corticosteroid for Asthma
September 22, 2008 (Issue: 1295)
The FDA has approved the marketing of the corticosteroid ciclesonide (Alvesco - Sepracor) in a hydrofluoroalkane (HFA) metered-dose inhaler formulation for maintenance treatment of asthma in patients >12 years old. Ciclesonide is also available in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.